Table 1 Serum Growth Hormone (GH), Insulin-like Growth Factor-1 (IGF-1) and Somatostatin (SOM) levels in normal female subjects and Systemic Lupus Erythematosus (SLE) patients
Group | Age (yrs)* | GH ng/ml)* | IGF-1 (nM/L)* | SOM (pg/ml)* | p-value |
|---|---|---|---|---|---|
All Normals (35) | 57.1 ± 13.1 | 1.17 ± 0.40 | 14.9 ± 3.6 | ||
(77) | <45 | 25.2 ± 11 | |||
(17) | 45–55 | 32.6 ± 12 | |||
(18) | >55 | 36.2 ± 10 | |||
Age- Matched Normals (18) | 30.8 ± 7.1** | 1.58 ± 1.16** | 25.0 ± 7.3† | ||
SLE (17) | 35.9 ± 8.6† | 1.45 ± 0.88† | 22.8 ± 7.1** | ||
(22) | < 45 | 29.8 ± 12 | P > 0.05 | ||
(12) | 45–55 | 35.4 ± 14 | P > 0.05 | ||
(21) | >55 | 29.9 ± 9 | P < 0.05 | ||
AMNv.SLE | **P > 0.05 | **P > 0.05 | **P > 0.05 | ||
ANv.SLE | †P < 0.001 | †P > 0.05 | †P < 0.001 |